<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Plasmodium falciparum malaria</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Plasmodium falciparum malaria.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/diseases/plasmodium-falciparum-malaria.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Wed, 09 Sep 2026 07:02:01 GMT</lastBuildDate>
  <item>
    <title>Retrospective study of association between Plasmodium falciparum malaria density and platelet count at Presbyterian Hospital, Agogo</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3389-fmala-2026-1875477-ea879f32/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3389-fmala-2026-1875477-ea879f32/</guid>
    <pubDate>Fri, 21 Aug 2026 00:00:00 GMT</pubDate>
    <description>Routine hematology analyzers may provide a swift, objective mechanism to prioritize suspected cases and streamline patient flow in settings where conventional parasitological testing encounters operational barriers.</description>
    <category>Plasmodium falciparum malaria</category>
    <category>Malaria</category>
    <category>Transmission dynamics</category>
    <category>Diagnostics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Extending the Duration of Artemether-Lumefantrine Treatment for Uncomplicated Plasmodium falciparum Malaria: Updated US Centers for Disease Control and Prevention Guidance Based on Review of Surveillance, Consultations, and Published Data</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciag456-d08fe121/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciag456-d08fe121/</guid>
    <pubDate>Wed, 19 Aug 2026 00:00:00 GMT</pubDate>
    <description>The article provides evidence relevant to treatment policy for uncomplicated Plasmodium falciparum malaria among travelers in the United States. Its findings were reported as informing updated CDC guidance, but this summary does not independently assess that guidance or connect the article with a live surveillance signal.</description>
    <category>Malaria</category>
    <category>Plasmodium falciparum malaria</category>
    <category>Treatment</category>
    <category>Surveillance</category>
    <category>Travel medicine</category>
    <category>Meta-analysis</category>
  </item>
  <item>
    <title>Malaria Transmission Via Needle Stick Injury: A Case Report and Systematic Review of the Literature.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1097-inf-0000000000005376-213986b0/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1097-inf-0000000000005376-213986b0/</guid>
    <pubDate>Mon, 17 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings document rare but recognized occupational transmission risk for healthcare workers managing malaria patients, emphasizing the need for standard precautions and post-exposure protocols in clinical settings where malaria is encountered.</description>
    <category>Malaria</category>
    <category>Plasmodium falciparum malaria</category>
    <category>Transmission dynamics</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Safety, pharmacokinetics, and antimalarial efficacy of single-dose cabamiquine–pyronaridine combination therapy for the treatment of adults and adolescents with acute uncomplicated Plasmodium falciparum malaria (CAPTURE 1): a prospective, multicentre, open-label, phase 2a study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-26-00233-1-eef5750a/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-26-00233-1-eef5750a/</guid>
    <pubDate>Wed, 01 Jul 2026 00:00:00 GMT</pubDate>
    <description>The formulation offers a potential therapeutic alternative as artemisinin resistance continues to challenge current standard treatments. Subsequent research will determine appropriate pediatric dosing and confirm durability through expanded clinical testing.</description>
    <category>Malaria</category>
    <category>Plasmodium falciparum malaria</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Failure of artemether-lumefantrine therapy in travellers returning to Belgium with Plasmodium falciparum malaria: an observational case series with genomic analysis</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-jtm-taad165-e49d6c94/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-jtm-taad165-e49d6c94/</guid>
    <pubDate>Fri, 29 Dec 2023 00:00:00 GMT</pubDate>
    <description>The findings identify treatment-failure cases among travellers returning from sub-Saharan Africa and describe genomic resistance markers detected in those cases. The authors state that systematic genomic monitoring among international travellers with P. falciparum malaria, particularly after treatment failure, is needed.</description>
    <category>Malaria</category>
    <category>Plasmodium falciparum malaria</category>
    <category>Travel medicine</category>
    <category>Treatment</category>
    <category>Surveillance</category>
    <category>Genomic epidemiology</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Estimated impact of RTS,S/AS01 malaria vaccine allocation strategies in sub-Saharan Africa: A modelling study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pmed-1003377-da55872d/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pmed-1003377-da55872d/</guid>
    <pubDate>Mon, 30 Nov 2020 00:00:00 GMT</pubDate>
    <description>The findings are framed as relevant to mitigating the effect of limited early RTS,S supply and to guiding geographic prioritisation if wider roll-out is recommended from 2021 onward.</description>
    <category>Malaria</category>
    <category>Plasmodium falciparum malaria</category>
    <category>Vaccination</category>
    <category>Transmission dynamics</category>
    <category>Vaccine effectiveness</category>
    <category>Climate and environment</category>
    <category>Mathematical modelling</category>
  </item>
  <item>
    <title>Outpatient treatment of imported uncomplicated Plasmodium falciparum malaria: results from a survey among TropNet and GeoSentinel experts for tropical medicine</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-jtm-taaa082-3b8f486e/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-jtm-taaa082-3b8f486e/</guid>
    <pubDate>Fri, 22 May 2020 00:00:00 GMT</pubDate>
    <description>The article is relevant as a snapshot of how imported malaria is managed in referral centers and shows substantial variation in outpatient practice. It may be useful for editors looking at practice heterogeneity and the need for more standardized evidence, but it does not by itself establish a live surveillance signal.</description>
    <category>Malaria</category>
    <category>Plasmodium falciparum malaria</category>
    <category>Surveillance</category>
    <category>Treatment</category>
    <category>Diagnostics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s0140-6736-15-00725-4-30b7693f/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s0140-6736-15-00725-4-30b7693f/</guid>
    <pubDate>Fri, 01 Jan 2016 00:00:00 GMT</pubDate>
    <description>The models predict significant public health impact and high cost-effectiveness of RTS,S/AS01 vaccination across a wide range of malaria transmission settings in Africa, though implementation decisions would need to consider local burden levels, existing intervention coverage and cost-effectiveness, health priorities, financing, and delivery system capacity.</description>
    <category>Malaria</category>
    <category>Plasmodium falciparum malaria</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Transmission dynamics</category>
    <category>Health policy</category>
    <category>Randomised controlled trial</category>
  </item>
</channel>
</rss>
